If your email program has trouble displaying this email, view as a webpage.

Thank you for subscribing to our newsletter. In an effort to consolidate information and effectively communicate with you, this newsletter will be eliminated after Sept. 2, 2022. As a result, you will find this information in the CDER New bulletin (example from July 21, 2022).

Drug Shortages

• FDA Drug Shortages
  • Adenosine Injection (New - Discontinuation)
  • Alprostadil Injection (New - Discontinuation)
  • Amikacin Sulfate Injection (New - Discontinuation)
  • Bleomycin Injection (New - Discontinuation)
  • Dacarbazine Injection (New - Discontinuation)
  • Daunorubicin Hydrochloride Injection (New - Discontinuation)
  • Desmopressin Acetate Injection (New - Discontinuation)
  • Epoprostenol Sodium for Injection and Sterile Diluent for Epoprostenol Sodium for Injection (New - Discontinuation)
  • Haloperidol Decanoate Injection (New - Discontinuation)
  • Vecuronium Bromide for Injection (Updated - Discontinuation)